 "Markets open higher tracking positive global cues")
Markets have started the trading session on firm note tracking firm global cues along with financials and IT shares leading the gains.
By 9:35, the 30-share Sensex was up 108 points at 20,419 and the 50-share Nifty was up 32 points at 6,068.
Foreign institutional investors (FIIs) bought shares worth a net Rs 10.75 crore on Thursday, as per provisional data from the stock exchanges.
The Dow Jones industrial average rose 187.14 points or 1.21%, to 15,627.37, the S&P 500 gained 21.76 points or 1.24%, to 1,773.4 and the Nasdaq Composite added 45.57 points or 1.14%, to 4,057.122.
Asian shares regained a measure of stability on Friday, stepping further away from five-month lows after a strong night on Wall Street and hopeful signs an upcoming crucial US jobs report will put to bed some of the global growth concerns.
In early trade, MSCI's broadest index of Asia-Pacific shares outside Japan rose 0.3%, a day after the index posted its biggest gains in over two months.
The index bounced 1.6% from a five-month low hit on Wednesday. Japan's Nikkei also rose 1.8%.
Back home, the rupee is trading at 62.32 per dollar vs previous close of 62.38.
On the sectoral front, BSE Realty, Healthcare and Metal indices have surged over 1% followed by counters like Oil & Gas, Banks, Capital Goods, Consumer Durables and IT, all gaining by nearly 1% each. Apart from FMCG, all the major BSE sectoral indices are trading in positive zone.
The main gainers on the Sensex at this hour include Tata Steel, Tata Power, Sun Pharma, Axis Bank, Sesa Sterlite, Cipla, SBI, ONGC and ICICI Bank.
On the losing side, ITC, NTPC, HUL and Hindalco have declined marginally.
Aurobindo Pharma has rallied 6% to Rs 525 after reporting over four-fold jumped in consolidated net profit at Rs 417 crore for the third quarter ended December 31, 2013 (Q3) on back of strong operational income. The pharmaceutical company had profit of Rs 92 crore in the same quarter previous fiscal.
The broader markets are outperforming the benchmark indices- BSE Midcap and Smallcap indices have gained between 0.5-1%.
The market breadth in BSE remains positive with 816 shares advancing and 248 shares declining.
By 9:35, the 30-share Sensex was up 108 points at 20,419 and the 50-share Nifty was up 32 points at 6,068.
Foreign institutional investors (FIIs) bought shares worth a net Rs 10.75 crore on Thursday, as per provisional data from the stock exchanges.
Also Read
US stocks rose the most so far this year on Thursday after a drop in applications for unemployment insurance boosted confidence in the economy, and as Disney's results overshot expectations.
The Dow Jones industrial average rose 187.14 points or 1.21%, to 15,627.37, the S&P 500 gained 21.76 points or 1.24%, to 1,773.4 and the Nasdaq Composite added 45.57 points or 1.14%, to 4,057.122.
Asian shares regained a measure of stability on Friday, stepping further away from five-month lows after a strong night on Wall Street and hopeful signs an upcoming crucial US jobs report will put to bed some of the global growth concerns.
In early trade, MSCI's broadest index of Asia-Pacific shares outside Japan rose 0.3%, a day after the index posted its biggest gains in over two months.
The index bounced 1.6% from a five-month low hit on Wednesday. Japan's Nikkei also rose 1.8%.
Back home, the rupee is trading at 62.32 per dollar vs previous close of 62.38.
On the sectoral front, BSE Realty, Healthcare and Metal indices have surged over 1% followed by counters like Oil & Gas, Banks, Capital Goods, Consumer Durables and IT, all gaining by nearly 1% each. Apart from FMCG, all the major BSE sectoral indices are trading in positive zone.
The main gainers on the Sensex at this hour include Tata Steel, Tata Power, Sun Pharma, Axis Bank, Sesa Sterlite, Cipla, SBI, ONGC and ICICI Bank.
On the losing side, ITC, NTPC, HUL and Hindalco have declined marginally.
Aurobindo Pharma has rallied 6% to Rs 525 after reporting over four-fold jumped in consolidated net profit at Rs 417 crore for the third quarter ended December 31, 2013 (Q3) on back of strong operational income. The pharmaceutical company had profit of Rs 92 crore in the same quarter previous fiscal.
The broader markets are outperforming the benchmark indices- BSE Midcap and Smallcap indices have gained between 0.5-1%.
The market breadth in BSE remains positive with 816 shares advancing and 248 shares declining.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%